ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio Corp. announced today that it is giving an oral presentation at the 2009 Immunotherapeutics & Vaccine Summit, which will include preclinical data demonstrating that its intranasal nanoemulsion adjuvant technology significantly enhances the immune response to influenza vaccines. The presentation details are as follows:
